Fig. 1
From: The correlation between HTA recommendations and reimbursement status of orphan drugs in Europe
![Fig. 1](http://media.springernature.com/full/springer-static/image/art%3A10.1186%2Fs13023-016-0501-4/MediaObjects/13023_2016_501_Fig1_HTML.gif)
Share (%) of orphan drugs assessed by HTA agency, by country. Source: Authors’ own calculations based on information from the websites of the eight HTA agencies